An update on selected cutaneous (myo) fibroblastic mesenchymal tumors
- PMID: 37150655
- PMCID: PMC10602371
- DOI: 10.1053/j.semdp.2023.04.018
An update on selected cutaneous (myo) fibroblastic mesenchymal tumors
Abstract
Cutaneous (myo)fibroblastic tumors constitute a group of tumors with overlapping clinicopathological features and variable biologic behavior. In the present review we focus on the histomorphology, immunohistochemical profile and molecular background of the following entities: dermatofibrosarcoma protuberans (DFSP), CD34-positive fibroblastic tumor (SCD34FT), myxoinflammatory sarcoma (MIFS), low-grade myofibroblastic sarcoma, solitary fibrous tumor and nodular fasciitis. Although some of these entities typically arise in deep-seated locations, they may occasionally present as cutaneous/superficial tumors and might be challenging to recognize. This review covers in depth the latest advances in molecular diagnostics and immunohistochemical markers that have significantly facilitated the correct classification and diagnosis of these neoplasms.
Keywords: Dermatofibrosarcoma protuberans; Low-grade myofibroblastic sarcoma; Myxoinflammatory fibroblastic sarcoma; Nodular fasciitis; Solitary fibrous tumor; Superficial CD34 fibroblastic tumor.
Copyright © 2023. Published by Elsevier Inc.
Conflict of interest statement
Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Figures
References
-
- Choi Joon Hyuk MD, PhD; Ro Jae Y. MD, PhD. Recent Advances in Fibroblastic/Myofibroblastic Tumors. AJSP: Reviews & Reports 22(2):p 124–134, March/April 2017. | DOI: 10.1097/PCR.0000000000000190 - DOI
-
- Slack JC, Bründler MA, Nohr E, McIntyre JB, Kurek KC (May 2021). “Molecular Alterations in Pediatric Fibroblastic/Myofibroblastic Tumors: An Appraisal of a Next Generation Sequencing Assay in a Retrospective Single Centre Study”. Pediatric and Developmental Pathology. 24 (5)421. doi: 10.1177/10935266211015558. - DOI - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
